Organised by
Sponsored by
Organised by
Sponsored by
Connect. Learn. Transform.
Nitrosamine impurities have become a critical concern across the pharmaceutical industry, driven by increasing regulatory scrutiny and the need for robust scientific and risk-based control strategies. As guidance from global regulators continues to evolve, companies are expected to proactively identify, assess, and mitigate nitrosamine risks throughout the product lifecycle.
This expert-led webinar, hosted by US Pharmacopeia (USP), explores the strategic and scientific approaches required to advance nitrosamine control-from detection and risk assessment to regulatory compliance and patient safety. Attendees will gain insights into USP’s scientific leadership in impurity standards, regulatory-aligned tools, and best practices to meet current expectations while future-proofing their quality systems.
Featured Speakers
Dr. Mrunal Jaywant 
Vice President R&D
U.S. Pharmacopeia
Why Attend / Key Takeaways
Understand evolving global regulatory requirements (FDA, EMA, CDSCO) for nitrosamines
Learn strategic approaches for risk assessment, control, and communication
Explore USP’s tools, reference standards, and general chapters (like <1469>) that support compliance
Hear real-world challenges and best practices in nitrosamine detection and mitigation
Gain confidence in implementing science-driven, lifecycle-based nitrosamine strategies
Participate in a live Q&A with leading USP expert
Express Pharma, first published as Express Pharma Pulse in 1994, is today India’s leading business fortnightly for the pharmaceutical industry. With the patronage of its readers, Express Pharma has grown to become the No.1 Business News Magazine for the pharmaceutical industry.
